IP Newsflash

On June 9, 2016, the United States Tax Court issued an opinion rejecting the Internal Revenue Service’s (IRS) proposed transfer pricing method that would have increased royalties payable to Medtronic, Inc. by $1.4 billion, calling the IRS’ proposed method arbitrary, capricious and unreasonable. The court instead accepted Medtronic’s chosen transfer pricing method with minor alterations.